Dr Aasia Ghazi, M.D
Dr. Aasia Ghazi graduated at the top of her class from a prestigious medical school in north India and earned a national award. She is passionate about her field of allergy, asthma and immunology, serving as a Clinical Assistant Professor in the division of Allergy and Immunology at UTMB Galveston in addition to her current practice. She is a member of the American College of Allergy, Asthma and Immunology as well as the American Academy of Allergy, Asthma and Immunology. Apart from her Allergy & Immunology practice, she volunteers at various clinics dedicated to offer medical care to uninsured patients. Her research interests include food allergy, mastocytosis and angioedema. She has presented multiple posters at national meetings. Dr. Ghazi is dedicated to providing quality care to her patients, and her expertise includes both adults and children.Residency: Exempla Saint Joseph Hospital residency program, in affiliation with the University of Colorado, Denver. Fellowship: University of Texas Medical Branch, Galveston, Texas Board Certifications: Allergy & Immunology; Internal Medicine
Dr. Ghazi interview with ABC News: "Most People with Inhalers, EpiPens Don't Use them Right"
Dallas Business Journal, April 21, 2014 "Nothing to sniff at: Dallas one of the nation's worst for allergies"
Dallas Morning News, April 2, 2013 "Dallas ranked 23rd worst U.S. city for allergies: how to defend yourself against mountain cedar and its high pollen buddies"
"Best Outgoing Medical Graduate" award presented by President of India (15th Annual Convocation, 1997)
"Certificate of Distinction" award presented by President of India (15th Annual Convocation, 1997)
"National Talent Award" by Government of India, 1988
ACAAI 2012; Classical Natural Killer deficiency- description of a rare case in a 58 year old female.
ACAAI 2011; Ectodermal Dysplasia and immunodeficiency in a 40 year old male - description of a rare case!
ACP 2007: Catatonia Resulting from Benzodiazepine Withdrawal!
ACP 2007: Neuroleptic Malignant Syndrome: a Life Threatening Complication.
ACP 2006; Necrotic Lymphadenopathy and systemic symptoms-Kikuchi’s disease.
"Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease.", November 18, 2014 Annals of Allergy Asthma Immunology
"Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report", May-June, 2014 Journal of Allergy and Clinical Immunology
"Hereditary angioedema: epidemiology, management, and role of icatibant." July 2013 Journal of Allergy Biologics
"Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma"." January 2012Expert Opinions in Biological Therapy